Eyelid Cutaneous Leishmaniasis: A Case Report

  • Moein DOROODGAR School of Medicine, Shahid Beheshti University of Medical Sciences, Tehran, Iran
  • Masoud DOROODGAR School of Medicine, Shahid Beheshti University of Medical Sciences, Tehran, Iran
  • Abbas DOROODGAR Dept. of Medical Parasitology, School of Medicine, Kashan University of Medical Sciences, Kashan, Iran
Keywords: Eyelid cutaneous leishmaniasis, Leishmania major, Ocular leishmaniasis

Abstract

Cutaneous leishmaniasis (CL) is the most common parasitic disease transmitted by vectors in Iran. CL is endemic in many urban and rural parts of Iran and usually caused by two species of Leishmania as L. major and L. tropica transmitted to humans from parasite reservoirs by the bite of female sandflies. We report a case of ocular leishmaniasis with eyelid involvement presentation. The patient was a 70-yr-old housewife woman referred to Health Care Center in city of Kashan, central Iran in 2012. The disease was diagnosed by direct smear, culture, and PCR from the lesion. PCR was positive for L. major. Her lesion was treated with systemic meglumine antimonate (Glucantime) (20 mg/kg/day) for 20 days.  

References

Service M (2009). Medical entomology for students. 4th ed. Cambridge University Press. UK. pp.: 93-102.

Modarres Zadeh M, Manshai K, Shaddel M, Oormazdi H (2006). Ocular Leishmania-sis, Review Article. Iran J Ophthalmol, 19(3): 1-5.

World Health Organization (2010). Control of the leishmaniases. Geneva [Online] http://whqlibdoc.who.int/trs/WHO_TRS_949_eng.pdf

Ministry of Health and Medical Education of Iran (2012). Care Guide Cutaneous Leishmaniasis in Iran. http://health.behdasht.gov.ir/?fkeyid=&siteid=435&pageid=53871&catid=289&dview=1189

Doroodgar A, Sayyah M, Doroodgar M, Mahbobi S, Nemetian M, Rafizadeh S, Rassi Y (2012). Progressive increasing of cutaneous leishmaniasis in Kashan dis-trict, central of Iran. Asian Pac J Trop Dis, 2(4): 260-263.

Hajjaran H, Mohebali M, Akhavan AA, Taheri A, Barikbin B, Nassiri S (2013). Unusual presentation of disseminated cu-taneous leishmaniasis due to Leishmania major: Case reports of four Iranian pa-tients. Asian Pac J Trop Med, 6(4):333-336.

Shiee MR, hajjaran H, Mohebali M, Do-roodgar A, Hashemisaadat M, Teimouri A, AfzaliH, Shirzadi MR (2012). A molec-ular and parasitological survey on cutane-ous leishmaniasis patients from historical city of Kashan in Isfahan province, cen-ter of Iran. Asian Pac J Trop Dis, 2(6): 421-425.

Veraldi S, Bottini S, Curr`o N , Gianotti R (2010). Leishmaniasis of the eyelid mim-icking an infundibular cyst and review of the literature on ocular leishmaniasis. Int J Infect Dis, 14 (Suppl 3): e230–2.

Ayatollahi J, Ayatollahi A and Shah Cheraghi H (2013). Cutaneous Leishmaniasis of the Eyelid: A Case Report. Case Rep Infect Dis,2013:214297.

Sadeghian G, NilforooshZadeh MA, Ansari N (2004). Palpebral Leishmaniasis with Trichiasis: A case report. Iran J Dermatol, 7(2): 112-115.

Satici A, Gurler B, Aslan G, Ozturk I (2004). Ocular involvement in cutaneous leish-maniasis: four cases with blepharocon-junctivitis. Eur J Epidemiol, 19(3): 263–266.

Ul Bari A, Rahman S.B (2008). Many faces of cutaneous leishmaniasis. Indian J Der-matol Venereol Leprol, 74(1):23-7.

Mortazavi H, Mohebali M, Taslimi Y, Sadeghipour P, Ansari M, Kamyab K, Talebi M, Khamesipour A (2015). Hoarseness as the Presenting Symptom of Visceral Leishmania-sis with Muco-Cutaneous Lesions: A Case Report. Iran J Parasitol, (10)2: 296-300.

Moravvej H, Barzegar M, Nasiri S, Abolhasani E, Mohebali M (2013). Cuta-neous Leishmaniasis with Unusual Clini-cal and Histological Presentation: Report of Four Cases. Acta Med Iran, 51(4): 274-8.

Abrishami M, Soheilian M, Farahi A, Dow-lati Y (2002). Successful treatment of ocu-lar leishmaniasis. Eur J Dermatol, 12(1): 88-9.

Khanjani Jafroodi S, Farazmand A, Amin M, Doroodgar A, Shirzadi MR, Razavi MR (2015). Methanolic Extract’s Activity of Artemisia absinthium, Vitexagnus-castus and Phytolaca americana Against Leishmania major; in vitro and in vivo. Int Arch Health Sci, 2(2): 69-74.

Griewank K, Gazeau C, Eichhorn A, Von Stebut E (2010). Miltefosine efficiently eliminates Leishmania major amastigotes from infected murine dendritic cells without altering their immune functions. Antimicrob Agents Chemother, 54(2):652-9

Haldar AK, Sen P, Roy S (2011). Use of Antimony in the Treatment of Leishman-iasis: Current Status and Future Direc-tions. Mol Biol Int, 2011:571242.

World Health Organization (2010). Leish-maniasis: Country profiles.

http://www.who.int/leishmaniasis/resources/IRAN.pdf?ua=1

Published
2017-02-12
How to Cite
1.
DOROODGAR M, DOROODGAR M, DOROODGAR A. Eyelid Cutaneous Leishmaniasis: A Case Report. Iran J Public Health. 46(2):261-264.
Section
Case Report(s)